CRNT trades 57.4% below Wall Street's consensus target of $4.25.
Last 12 months price action with 12-month analyst target path
The base valuation assumes CRNT achieves its forward estimates and maintains a stable P/E multiple of 20.1x. This scenario reflects the blended consensus of 6 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 19, 2026, Ceragon Networks Ltd. (CRNT) has a Wall Street consensus price target of $4.25, based on estimates from 6 covering analysts. With the stock currently trading at $2.70, this represents a potential upside of +57.4%. The company has a market capitalization of $243M.
Analyst price targets range from a low of $4.00 to a high of $4.50, representing a 12% spread in expectations. The median target of $4.25 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 5 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, CRNT trades at a trailing P/E of -115.9x and forward P/E of 20.1x. Analysts expect EPS to grow +596.3% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $0.23, with bear and bull scenarios of $0.15 and $0.30 respectively. Model confidence stands at 40/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
AVNWAviat Networks, Inc. | $259M | $20.04 | $31.33 | +56.3% | Buy | 12.8x | 12 |
SATSEchoStar Corporation | $31.5B | $109.17 | $144.00 | +31.9% | Buy | 314.9x | 11 |
GILTGilat Satellite Networks Ltd. | $842M | $13.19 | $20.00 | +51.6% | Buy | 22.2x | 2 |
UTSIUTStarcom Holdings Corp. | $24M | $2.64 | — | — | — | — | — |
CIENCiena Corporation | $60.6B | $428.22 | $493.42 | +15.2% | Buy | 65.6x | 42 |
ADTNADTRAN Holdings, Inc. | $1.2B | $15.18 | $18.00 | +18.6% | Buy | 28.8x | 25 |
CALXCalix, Inc. | $2.5B | $37.95 | $61.00 | +60.7% | Buy | 21.4x | 21 |
VIAVViavi Solutions Inc. | $10.9B | $47.17 | $32.25 | -31.6% | Buy | 50.3x | 19 |
DCOMDime Community Bancshares, Inc. | $1.7B | $39.00 | $39.50 | +1.3% | Hold | 11.6x | 10 |
CSCOCisco Systems, Inc. | $471.2B | $119.54 | $123.30 | +3.1% | Buy | 28.0x | 73 |
Quick answers to the most common questions about buying CRNT stock.
The consensus Wall Street price target for CRNT is $4.25, representing 57.4% upside from the current price of $2.7. With 6 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
CRNT has a consensus rating of "Buy" based on 6 Wall Street analysts. The rating breakdown is predominantly bullish, with 5 Buy/Strong Buy ratings. The consensus 12-month price target of $4.25 implies 57.4% upside from current levels.
CRNT trades at a forward P/E of 20.1493x, representing a moderate valuation. With analysts targeting $4.25 (57.4% implied move), the stock appears reasonably valued with upside.
The most bullish Wall Street analyst has a price target of $4.5 for CRNT, while the most conservative target is $4. The consensus of $4.25 represents the median expectation. Our quantitative valuation model projects a bull case target of $0 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CRNT is moderately covered, with 6 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 5 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CRNT stock forecast based on 6 Wall Street analysts shows a consensus price target of $4.25, with estimates ranging from $4 (bear case) to $4.5 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $0, with bear/bull scenarios of $0/$0.
Our quantitative valuation model calculates CRNT's fair value at $0 (base case), with a bear case of $0 and bull case of $0. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 40/100.
CRNT trades at a forward P/E ratio of 20.1x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on CRNT, with a "Buy" consensus rating and $4.25 price target (57.4% upside). 5 of 6 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CRNT analyst price targets range from $4 to $4.5, a 12% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $4.25 consensus represents the middle ground. Our model's $0-$0 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.